Graham Gullans

Dr. Una Ryan serves as Managing Director at Golden Seeds. She is currently Research Professor of Medicine at BU School of Medicine and serves on its Board of Visitors. Her board positions include AMRI (Lead Director, Nominating and Compensation committees) and MSH (Audit and Compensation committees). Dr. Ryan was most recently President and CEO of Diagnostics For All (DFA), a non-profit organization developing inexpensive diagnostics for global health and agricultural uses. Previously, she was President and CEO of AVANT Immunotherapeutics, Inc, (NASDAQ) a company developing vaccines and immunotherapeutics for cancer, travelers, food safety, and global health, and also a member of its Board of Directors. Prior to AVANT, she was director of Health Sciences at Monsanto Company. Before that, she held a number of positions in academia, including Research Professor of Surgery at Washington University School of Medicine in St. Louis and Professor of Medicine at the University of Miami School of Medicine. She was also Chair of the Massachusetts Biotechnology Council, served on its Board, as well as the Biotechnology Industry Organization, New England Healthcare Institute, Board of Associates of the Whitehead Institute, Strategy & Policy Council of the MIT Center for Biomedical Innovation, Massachusetts Life Sciences Collaborative Leadership Council and the Goddard Council on science, technology, engineering and mathematics education. Dr. Ryan holds a PhD in Cellular and Molecular Biology from Cambridge University and BS degrees in Zoology, Microbiology and Chemistry from Bristol University. She received an Honorary Doctor of Science degree from Bristol University in 2009. In 2007, Dr. Ryan received the Albert Einstein Award for outstanding achievement in the life sciences. In 2002 Her Majesty Queen Elizabeth II awarded Dr. Ryan the Order of the British Empire (OBE) for services to research, development and promotion of biotechnology. She is also an Angel Investor. She also serves as a Board Member at Nativis.

Angel NetworkMenlo Park, United States

Sand Hill Angels

Mr. Sherman Ting serves as President Emiritus and Board Member at Sand Hill Angels. Sherman has over 25 years of experience in the high technology industry, in engineering, executive management and as an entrepreneur. He is an active investor in start-up ventures. Most recently, Sherman was Founder and CEO of Century A Technologies, a company which built a marketing/sales/support infrastructure in China, for new breeds of Internet-based enterprise software products designed in the US. Previously, Sherman was Vice President at Oracle Corporation, where he founded the HP Products Division and grew the business into the number one product line, with over $300M in product license revenue. While at Oracle, he also established the Asia Products Division to spearhead the cultivation of business in the Asia Pacific region, which later became the fastest growing market for Oracle. As a result, Oracle's Japanese subsidiary experienced one of the most successful high tech IPOs in Japanese history. In addition, Sherman was on the Oracle CEO's hand-picked team to start up a Network Computer business, to revolutionize how people and businesses use the Internet. Prior to Oracle, Sherman held engineering positions at Hewlett Packard, developing relational database systems for HP's cutting edge RISC computer servers and at Intel, developing computer language processors for Intel's advanced chip architecture. Sherman received an MSE in Computer Science from the University of Pennsylvania.

Broadway Angels

Broadway Angels is an angel investment group made up of world-class investors and business executives who all happen to be women. We all have decades of experience investing in and managing the best technology companies in the world. All of us are or have been general partners in venture capital firms or senior executives in top technology and consumer companies. For most of us, we have been the only woman partner or senior executive in our firm. All of us have built great careers and portfolios along with amazing relationships with entrepreneurs and executives. Broadway Angels invests in the very best people and ideas in start-up and growing companies. Most of our investments are in information technology, an area we all know best, but we are also open to other opportunities too. We are small investors and typically invest only a fraction of the total amount raised. We are great team players and work well with other angels and venture capital firms. We typically do not take board seats but serve as excellent advisers and sounding boards to management teams.

EdTech

Angel NetworkSan Mateo, United States

Seraph Group

Mr. Tuff Yen serves as President at Seraph Group. He is also a board member of iSpionage. He spent his career as a scientist and a professional investor. He worked as a venture capitalist with Hambrecht & Quist's venture fund ("HQAP") in San Francisco as well as Chemical Bank’s venture arm in New York City. During this period, he worked on investments in a broad range of businesses including industrial manufacturing, distribution, entertainment, publishing, information technology, Internet, medical and life sciences. Prior to joining the VC community, he was a bioengineer with Genentech and worked at Amgen, two leading biotechnology pioneers. He received his masters in business administration from the Yale School of Management and his bachelor degree in Arts in microbiology and immunology from the University of California Berkeley.

$100K – $2M

Cross Border Angels

Cross Border Angels is an angel group which help investors to co-invest in international deals with experienced investors and experts and assist companies to raise funds from the members in various countries. It belongs to Scaale Group of companies which are growth consultants dedicated to help companies through capital, sales and talent. It seeks to invest in the iot, cloud, mobile, artificial intelligence, ecommerce, marketplaces, media, high tech, clean tech, medical devices, real estate, logistics, growth oriented manufacturing, distribution companies, consumer products, retail, food, travel tech, edu-tech, hospitality, smart city tech, smart infrastructure and health care sectors. The firm was founded in 2013 and has an office in San Francisco, California with additional offices in the USA, Europe and Asia.

Venture-med

Commercial ServicesSoftware

Venture-Med is an exclusive membership organization of accredited investors who want to be introduced to innovative healthcare startups and related investment opportunities. They are one of the newest angel investment groups in Silicon Valley and they offer their members a screening process to find the best innovative new companies seeking seed funding and mentorship.Theirfocus is on healthcare and they provide the entrepreneur the expertise to guide and successfully fund.They provide them with representation for syndication with other angel investment groups. This creates a win for the investor and the entrepreneur. They have monthly presentations by the most qualified and screened healthcare startup companies.